Glial Tumors Electromagnetic Signature Study by MagnetoEncephaloGraphy (MEG) "CONDUCTOME"

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE1

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2018-01-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the correlation between functional MEG analysis of the tumor and its periphery and the tumor stage and treatment response.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study

NCT01872221

Glioblastoma

COMPLETED NA

Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs

NCT06203496

Glioma, Malignant

RECRUITING

Mapping of Electrical Properties in the Brain

NCT06470711

Malignant Glioma

RECRUITING

Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas

NCT02795364

Glioma Anaplastic Oligoastrocytoma Glioblastomas (GBM)

UNKNOWN NA

Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma

NCT01305122

OMS Grade II Glioma

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A better tumor grade definition would provide an optimized surgical care, prognosis and therapeutical response evaluation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Primitive Tumor With Chirurgical Indication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CONDUCTOME

MEG and MRI

Group Type EXPERIMENTAL

MEG and MRI

Intervention Type OTHER

CONDUCTOME

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MEG and MRI

CONDUCTOME

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* more or equal than 18 years old
* patient affiliated to social security or similarly regime
* informed consent form signed
* supra-tentorial primitive cerebral tumor

Exclusion Criteria

* Pregnant women and lactating mothers
* Ward of court or under guardianship
* Adult unable to express their consent
* Person deprived of freedom by judicial or administrative decision
* Person hospitalized without their consent
* Person under legal protection
* Magnetic Resonance Imaging (MRI) contraindication (implanted material non MRI-compatible, ferro-magnetic foreign body, claustrophobia)
* Patients needed emergency medical care for other pathology
* severely altered general health (Performance Status 3 or 4)

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes